Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | GS-9716 |
Trade Name | |
Synonyms | GS 9716|GS9716 |
Drug Descriptions |
GS-9716 inhibits MCL1, potentially leading to decreased tumor cell viability and inhibition of tumor growth and tumor regression (Cancer Res 2022;82(12_Suppl):Abstract nr 3696). |
DrugClasses | MCL1 Inhibitor 18 |
CAS Registry Number | NA |
NCIT ID | C182614 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Docetaxel + Gemcitabine + GS-9716 | Docetaxel GS-9716 Gemcitabine | 0 | 0 |
Docetaxel + GS-9716 | Docetaxel GS-9716 | 0 | 1 |
GS-9716 | GS-9716 | 0 | 1 |
GS-9716 + Paclitaxel | GS-9716 Paclitaxel | 0 | 0 |
GS-9716 + Sacituzumab govitecan-hziy | GS-9716 Sacituzumab govitecan-hziy | 0 | 1 |